Poractant alfa (Curosurf): Supply issue resolved

In January 2021 we notified supply issues for the 240 mg and 120 mg solutions.

Resolved 11 February 2021

We're advised that both presentations of poractant alfa (Curosurf) have been resupplied.

The supply issue is caused by higher than usual usage of both presentations. This is made more challenging by the transport disruptions caused by COVID-19.

The supplier is arranging to air freight additional stock in early February. They will also communicate to the sector.

Poractant alfa is only listed in the Hospital Medicine List.  

Who to contact

If you have questions about this supply issue, we recommend talking to the supplier or your wholesaler.